UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Gastroenteropancreatic neuroendocrine tumours

The lancet oncology, 2008, Vol.9 (1), p.61-72

2008

Volltextzugriff (PDF)

Treatment of patients with gastro-entero-pancreatic (GEP) tumours with the novel radiolabelled somatostatin analogue [177Lu-DOTA0, Tyr3]octreotate

European journal of nuclear medicine and molecular imaging, 2003-03, Vol.30 (3), p.417-422

2003

Volltextzugriff (PDF)

Rare NOX3 Variants Confer Susceptibility to Agranulocytosis During Thyrostatic Treatment of Graves' Disease

Clinical pharmacology and therapeutics, 2017-12, Vol.102 (6), p.1017-1024

2017

Volltextzugriff (PDF)

Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Tumours: Well-Differentiated Tumour/Carcinoma of the Appendix and Goblet Cell Carcinoma

Neuroendocrinology, 2008-01, Vol.87 (1), p.20-30

2008

Volltextzugriff (PDF)

ENETS Consensus Guidelines Update for Gastroduodenal Neuroendocrine Neoplasms

Neuroendocrinology, 2016-01, Vol.103 (2), p.119-124

2016

Volltextzugriff (PDF)

ENETS Consensus Guidelines Update for Colorectal Neuroendocrine Neoplasms

Neuroendocrinology, 2016-01, Vol.103 (2), p.139-143

2016

Volltextzugriff (PDF)

Hypercoagulability in Cushing's syndrome: prevalence, pathogenesis and treatment

Clinical endocrinology (Oxford), 2013-04, Vol.78 (4), p.481-488

2013

Volltextzugriff (PDF)

Strategies Towards Improving Clinical Outcomes of Peptide Receptor Radionuclide Therapy

Current oncology reports, 2021-04, Vol.23 (4), p.46, Article 46

2021

Volltextzugriff (PDF)

Unfavorable biological behavior and treatment response of neuroendocrine ovarian metastases of midgut neuroendocrine tumors

Endocrine-related cancer, 2023-08, Vol.30 (8), p.1

2023

Volltextzugriff (PDF)

Radiolabeled Somatostatin Analog [177Lu-DOTA0,Tyr3]Octreotate in Patients With Endocrine Gastroenteropancreatic Tumors

Journal of clinical oncology, 2005-04, Vol.23 (12), p.2754-2762

2005

Volltextzugriff (PDF)

Clinical Syndromes Related to Gastrointestinal Neuroendocrine Neoplasms

Frontiers of hormone research, 2015-01, Vol.44, p.40

2015

Volltextzugriff (PDF)

Analyse prognostisch relevanter Faktoren bei fortgeschrittenen neuroendokrinen Tumoren des Pankreas

Zeitschrift für Gastroenterologie, 2016, Vol.54 (8)

2016

Volltextzugriff (PDF)

Combined treatment for acromegaly with long-acting somatostatin analogs and pegvisomant: long-term safety for up to 4.5 years (median 2.2 years) of follow-up in 86 patients

European journal of endocrinology, 2009-04, Vol.160 (4), p.529-533

2009

Volltextzugriff (PDF)

The multi-ligand somatostatin analogue SOM230 inhibits ACTH secretion by cultured human corticotroph adenomas via somatostatin receptor type 5

European journal of endocrinology, 2005-04, Vol.152 (4), p.645-654

2005

Volltextzugriff (PDF)

Combined therapy with somatostatin analogues and weekly pegvisomant in active acromegaly

The Lancet (British edition), 2005-05, Vol.365 (9471), p.1644-1646

2005

Volltextzugriff (PDF)

Biochemical Testing in Patients with Neuroendocrine Tumors

Frontiers of hormone research, 2015-01, Vol.44, p.24

Granberg, Dan

2015

Volltextzugriff (PDF)

Dopamine Receptor Expression and Function in Corticotroph Pituitary Tumors

The journal of clinical endocrinology and metabolism, 2004-05, Vol.89 (5), p.2452-2462

2004

Volltextzugriff (PDF)

Pregnancy-related hemangioblastoma progression and complications in von Hippel-Lindau disease

Neurology, 2012-08, Vol.79 (8), p.793-796

2012

Volltextzugriff (PDF)

The Novel Somatostatin Analog SOM230 Is a Potent Inhibitor of Hormone Release by Growth Hormone- and Prolactin-Secreting Pituitary Adenomas in Vitro

The journal of clinical endocrinology and metabolism, 2004-04, Vol.89 (4), p.1577-1585

2004

Volltextzugriff (PDF)

Well-Differentiated Pancreatic Tumor/Carcinoma: Insulinoma

Neuroendocrinology, 2006-01, Vol.84 (3), p.183-188

2006

Volltextzugriff (PDF)

Octreotide

The New England journal of medicine, 1996-01, Vol.334 (4), p.246-254

1996

Volltextzugriff (PDF)

A Single-Dose Comparison of the Acute Effects between the New Somatostatin Analog SOM230 and Octreotide in Acromegalic Patients

The journal of clinical endocrinology and metabolism, 2004-02, Vol.89 (2), p.638-645

2004

Volltextzugriff (PDF)

Phase I study of peptide receptor radionuclide therapy with [ 111In-DTPA 0]octreotide: The rotterdam experience

Seminars in nuclear medicine, 2002-04, Vol.32 (2), p.110-122

2002

Volltextzugriff (PDF)

The peripheral blood compartment in patients with Graves' disease: activated T lymphocytes and increased transitional and pre‐naive mature B lymphocytes

Clinical and experimental immunology, 2013-11, Vol.174 (2), p.256-264

2013

Volltextzugriff (PDF)

[123I]Metaiodobenzylguanidine and [111In]octreotide uptake in benign and malignant pheochromocytomas

The journal of clinical endocrinology and metabolism, 2001-02, Vol.86 (2), p.685-693

2001

Volltextzugriff (PDF)

1 – 25 von 154

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(147)
Mit Volltextzugriff
(108)

Publikationsform

Sprache

Englisch
(153)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(143)
Life Sciences & Biomedicine
(142)
Humans
(132)
Endocrinology & Metabolism
(96)
Biological And Medical Sciences
(81)
Medical Sciences
(69)
Male
(61)
Female
(57)
Middle Aged
(53)
Adult
(48)
Endocrinopathies
(38)
Aged
(31)
Non Tumoral Diseases. Target Tissue Resistance. Benign Neoplasms
(30)
Somatostatin - Analogs & Derivatives
(29)
Fundamental And Applied Biological Sciences. Psychology
(26)
Octreotide - Therapeutic Use
(22)
Vertebrates: Endocrinology
(21)
Pathology
(20)
Endocrinology
(19)
Hypothalamus. Hypophysis. Epiphysis
(18)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Gastroenteropancreatic neuroendocrine tumours

Treatment of patients with gastro-entero-pancreatic (GEP) tumours with the novel radiolabelled somatostatin analogue [177Lu-DOTA0, Tyr3]octreotate

Rare NOX3 Variants Confer Susceptibility to Agranulocytosis During Thyrostatic Treatment of Graves' Disease

Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Tumours: Well-Differentiated Tumour/Carcinoma of the Appendix and Goblet Cell Carcinoma

ENETS Consensus Guidelines Update for Gastroduodenal Neuroendocrine Neoplasms

ENETS Consensus Guidelines Update for Colorectal Neuroendocrine Neoplasms

Hypercoagulability in Cushing's syndrome: prevalence, pathogenesis and treatment

Strategies Towards Improving Clinical Outcomes of Peptide Receptor Radionuclide Therapy

Unfavorable biological behavior and treatment response of neuroendocrine ovarian metastases of midgut neuroendocrine tumors

Radiolabeled Somatostatin Analog [177Lu-DOTA0,Tyr3]Octreotate in Patients With Endocrine Gastroenteropancreatic Tumors

Clinical Syndromes Related to Gastrointestinal Neuroendocrine Neoplasms

Analyse prognostisch relevanter Faktoren bei fortgeschrittenen neuroendokrinen Tumoren des Pankreas

Combined treatment for acromegaly with long-acting somatostatin analogs and pegvisomant: long-term safety for up to 4.5 years (median 2.2 years) of follow-up in 86 patients

The multi-ligand somatostatin analogue SOM230 inhibits ACTH secretion by cultured human corticotroph adenomas via somatostatin receptor type 5

Combined therapy with somatostatin analogues and weekly pegvisomant in active acromegaly

Biochemical Testing in Patients with Neuroendocrine Tumors

Dopamine Receptor Expression and Function in Corticotroph Pituitary Tumors

Pregnancy-related hemangioblastoma progression and complications in von Hippel-Lindau disease

The Novel Somatostatin Analog SOM230 Is a Potent Inhibitor of Hormone Release by Growth Hormone- and Prolactin-Secreting Pituitary Adenomas in Vitro

Well-Differentiated Pancreatic Tumor/Carcinoma: Insulinoma

Octreotide

A Single-Dose Comparison of the Acute Effects between the New Somatostatin Analog SOM230 and Octreotide in Acromegalic Patients

Phase I study of peptide receptor radionuclide therapy with [ 111In-DTPA 0]octreotide: The rotterdam experience

The peripheral blood compartment in patients with Graves' disease: activated T lymphocytes and increased transitional and pre‐naive mature B lymphocytes

[123I]Metaiodobenzylguanidine and [111In]octreotide uptake in benign and malignant pheochromocytomas

Suchergebnisse filtern